Department of Gastroenterology, Christchurch Hospital, Christchurch, Canterbury, New Zealand.
Hepatology. 2013 Jun;57(6):2399-406. doi: 10.1002/hep.26290. Epub 2013 May 1.
Autoimmune hepatitis (AIH) can lead to cirrhosis, hepatic failure, and death. We aimed to identify predictors of advanced liver fibrosis at presentation, predictors of incomplete response to initial immunosuppression, and predictors of poor liver-related outcomes in the population-based AIH cohort from Canterbury, New Zealand. Cases diagnosed after 1980 that fulfilled standard diagnostic criteria were included. Cases were censored at death or liver transplantation and had a median follow-up of 9 years. Analyses were performed with Cox proportional hazards regression and logistic binary regression. The times to event outcomes were summarized using Kaplan-Meier curves. A total of 133 AIH patients were included. Predictors for advanced liver fibrosis at diagnosis were age at presentation of ≤20 years or >60 years (P = 0.02), serum albumin <36 g/L (P < 0.01), platelet <150 U/L (P < 0.01), and International Normalized Ratio (INR) >1.2 (P < 0.01). The only independent predictor for incomplete normalization of alanine aminotransferase (ALT) at 6 months was age at presentation ≤20 years. Independent predictors of poor liver-related outcomes were incomplete normalization of ALT at 6 months (P < 0.01), serum albumin <36 g/L (P < 0.01), and age at presentation of ≤20 years or >60 years (P = 0.01). Kaplan-Meier estimates showed that 10-year adverse liver event-free survival was 80% for age at presentation ≤20 years and >60 years, and 93% and 100% for age at presentation between 21-40 years and 41-60 years, respectively.
Incomplete normalization of ALT at 6 months, low serum albumin concentration at diagnosis, and age at presentation of ≤20 years or >60 years were significant independent predictors of liver-related death or requirement for liver transplantation. Histological cirrhosis at diagnosis was not associated with poor prognosis and did not influence the response to initial immunosuppressive treatment. (HEPATOLOGY 2013;57:2399-2406).
本研究旨在识别新泽西安大略省坎特伯雷基于人群的自身免疫性肝炎(AIH)队列中,患者在初诊时出现晚期肝纤维化、对初始免疫抑制治疗无应答以及发生不良肝脏结局的预测因子。
1980 年后诊断为 AIH 且符合标准诊断标准的患者。
无。
对符合标准的患者进行回顾性分析,应用 Cox 比例风险回归和 logistic 二项回归进行分析,Kaplan-Meier 曲线总结时间相关事件结果。
共纳入 133 例 AIH 患者。诊断时存在晚期纤维化的预测因子为初诊时年龄≤20 岁或>60 岁(P = 0.02)、血清白蛋白<36 g/L(P<0.01)、血小板<150 U/L(P<0.01)和国际标准化比值(INR)>1.2(P<0.01)。6 个月时丙氨酸氨基转移酶(ALT)未完全正常的唯一独立预测因子是初诊时年龄≤20 岁。不良肝脏结局的独立预测因子为 6 个月时 ALT 未完全正常(P<0.01)、血清白蛋白<36 g/L(P<0.01)以及初诊时年龄≤20 岁或>60 岁(P = 0.01)。Kaplan-Meier 估计显示,初诊时年龄≤20 岁或>60 岁的患者,10 年不良肝脏事件无复发生存率为 80%,年龄在 21-40 岁和 41-60 岁的患者,10 年无不良肝脏事件无复发生存率分别为 93%和 100%。
6 个月时 ALT 未完全正常、初诊时血清白蛋白浓度低以及初诊时年龄≤20 岁或>60 岁是与肝脏相关死亡或需要肝移植相关的显著独立预测因子。诊断时存在肝纤维化并不预示不良预后,也不影响初始免疫抑制治疗的反应。